You are here

Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Reykjavik, , 101 Iceland
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Invasive Pneumococcal Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
5-8 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Fully vaccinated children who participated in a previous Wyeth study (Study D139-P506)
and received a booster dose of either 23-valent pneumococcal polysaccharide vaccine
(PPV23) or pneumococcal conjugate vaccine (PnCV) per the original protocol for that
study.

- Subjects must be in good health as determined by medical history, physical examination
and clinical judgment.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Known allergy to any component of the 7-valent pneumococcal conjugate vaccine (7vPnC)
or 13-valent pneumococcal conjugate vaccine (13vPnC).

- History of documented invasive pneumococcal disease (defined as a positive culture of
S. pneumoniae from a normally sterile body site).

- Any known or suspected disease or dysfunction of the immune system, including: HIV
infection, Malignancy, Receipt of immunosuppressive therapy, Sickle cell
hemoglobinopathy.

- Receipt of immune-globulin within the past 3 months.

- Receipt of either PSV or 7vPnCV since the completion of Study D139-P506.

NCT00853749
Pfizer
Completed
Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now